Jens‐Oliver Koopmann

1.5k total citations
16 papers, 897 citations indexed

About

Jens‐Oliver Koopmann is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jens‐Oliver Koopmann has authored 16 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Immunology and 3 papers in Oncology. Recurrent topics in Jens‐Oliver Koopmann's work include Immunotherapy and Immune Responses (6 papers), RNA Interference and Gene Delivery (3 papers) and Immune Cell Function and Interaction (3 papers). Jens‐Oliver Koopmann is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), RNA Interference and Gene Delivery (3 papers) and Immune Cell Function and Interaction (3 papers). Jens‐Oliver Koopmann collaborates with scholars based in Germany, Netherlands and United Kingdom. Jens‐Oliver Koopmann's co-authors include Günter J. Hämmerling, Frank Momburg, Jacques Neefjes, Thomas Flohr, Walter Muranyi, Els Goulmy, Hartmut Hengel, Ulrich H. Koszinowski, Jörn C. Albring and Pieter Spee and has published in prestigious journals such as Immunity, Journal of Hepatology and British Journal of Cancer.

In The Last Decade

Jens‐Oliver Koopmann

16 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens‐Oliver Koopmann Germany 11 512 349 279 256 76 16 897
Margret Müller Germany 8 492 1.0× 399 1.1× 312 1.1× 166 0.6× 46 0.6× 10 870
Monique Grommé Netherlands 9 733 1.4× 588 1.7× 167 0.6× 219 0.9× 61 0.8× 10 1.1k
Christine Zimmermann Germany 16 667 1.3× 339 1.0× 212 0.8× 175 0.7× 59 0.8× 26 1.0k
Grazia Camarda Italy 17 423 0.8× 546 1.6× 171 0.6× 231 0.9× 42 0.6× 23 1.3k
Begoña Galocha Spain 16 709 1.4× 288 0.8× 356 1.3× 122 0.5× 54 0.7× 26 1.2k
Gregory A. Korbel United States 10 280 0.5× 562 1.6× 249 0.9× 201 0.8× 78 1.0× 12 888
Victoria L. Crotzer United States 11 486 0.9× 325 0.9× 261 0.9× 90 0.4× 40 0.5× 13 811
Stephan Uebel Germany 14 643 1.3× 558 1.6× 391 1.4× 437 1.7× 87 1.1× 19 1.3k
Casper Paludan United States 8 921 1.8× 260 0.7× 630 2.3× 351 1.4× 46 0.6× 9 1.4k
Maja Marić United States 18 855 1.7× 277 0.8× 149 0.5× 155 0.6× 50 0.7× 25 1.1k

Countries citing papers authored by Jens‐Oliver Koopmann

Since Specialization
Citations

This map shows the geographic impact of Jens‐Oliver Koopmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens‐Oliver Koopmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens‐Oliver Koopmann more than expected).

Fields of papers citing papers by Jens‐Oliver Koopmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens‐Oliver Koopmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens‐Oliver Koopmann. The network helps show where Jens‐Oliver Koopmann may publish in the future.

Co-authorship network of co-authors of Jens‐Oliver Koopmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jens‐Oliver Koopmann. A scholar is included among the top collaborators of Jens‐Oliver Koopmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens‐Oliver Koopmann. Jens‐Oliver Koopmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Harper, James A., Shannon Burke, Jon Travers, et al.. (2021). Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity. Molecular Cancer Therapeutics. 20(9). 1723–1734. 10 indexed citations
2.
Poon, Edmund, Stefanie Mullins, Amanda Watkins, et al.. (2017). The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment. Journal for ImmunoTherapy of Cancer. 5(1). 63–63. 59 indexed citations
3.
McAndrew, Michael B., et al.. (2013). SAT0528 Novel Autoantibody Biomarkers for the Improved Diagnosis of Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases. 72. A760–A760. 2 indexed citations
4.
Koopmann, Jens‐Oliver & Jonathan M. Blackburn. (2003). High affinity capture surface for matrix‐assisted laser desorption/ionisation compatible protein microarrays. Rapid Communications in Mass Spectrometry. 17(5). 455–462. 22 indexed citations
5.
Albring, Jörn C., Jens‐Oliver Koopmann, Günter J. Hämmerling, & Frank Momburg. (2003). Retrotranslocation of MHC class I heavy chain from the endoplasmic reticulum to the cytosol is dependent on ATP supply to the ER lumen. Molecular Immunology. 40(10). 733–741. 10 indexed citations
6.
Bai, Lianhua, et al.. (2002). Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients. International Journal of Oncology. 21(4). 685–94. 54 indexed citations
7.
Koopmann, Jens‐Oliver, Jörn C. Albring, Eva N. Huter, et al.. (2000). Export of Antigenic Peptides from the Endoplasmic Reticulum Intersects with Retrograde Protein Translocation through the Sec61p Channel. Immunity. 13(1). 117–127. 133 indexed citations
8.
Koopmann, Jens‐Oliver, Frank Dombrowski, Jürgen K. Rockstroh, et al.. (2000). Fatal Pneumonia in an AIDS Patient Coinfected with Adenovirus and Pneumocystis carinii. Infection. 28(5). 323–325. 9 indexed citations
9.
Schneiders, Anke, Mareike Schulz, Ludger Leifeld, et al.. (2000). E2 antibodies mediate antibody dependent cellular cytotoxicity in HCV. Journal of Hepatology. 32. 37–37. 2 indexed citations
10.
Grommé, Monique, Rob M. J. Liskamp, Günter J. Hämmerling, et al.. (1997). The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics. European Journal of Immunology. 27(4). 898–904. 41 indexed citations
11.
Hengel, Hartmut, Jens‐Oliver Koopmann, Thomas Flohr, et al.. (1997). A Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter. Immunity. 6(5). 623–632. 266 indexed citations
12.
Koopmann, Jens‐Oliver, et al.. (1997). Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Current Opinion in Immunology. 9(1). 80–88. 89 indexed citations
13.
Koopmann, Jens‐Oliver, et al.. (1996). Translocation of long peptides by transporters associated with antigen processing (TAP). European Journal of Immunology. 26(8). 1720–1728. 116 indexed citations
14.
Koopmann, Jens‐Oliver, David Maintz, Steven E. Schild, et al.. (1995). Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours. British Journal of Cancer. 72(5). 1230–1233. 55 indexed citations
15.
Kayser, Gian, et al.. (1995). Expression of lectin, interleukin-2 and histopathologic blood group binding sites in prostate cancer and its correlation with integrated optical density and syntactic structure analysis.. PubMed. 17(2). 135–42. 21 indexed citations
16.
Koopmann, Jens‐Oliver, et al.. (1993). Gel-Immobilized Heparin-Binding Lectin as Sensitive Sensor for Certain Groups of Charge-Bearing Carbohydrates. Biological Chemistry Hoppe-Seyler. 374(7-12). 1029–1032. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026